GigaGen
  • Our Company
    • Team
    • News
  • Our Science
    • Surge and Magnify Technologies
    • Publications, Scientific Posters & Presentations
  • Pipeline
    • Oncology
    • Recombinant Polyclonals
  • Careers
  • Contact
  • Menu Menu

GigaGen closes $50M deal with Grifols

News, Uncategorized

GigaGen has received $35 million in investment funding and $15 million licensing fee payment from Grifols.

Read the full story from Endpoints:

An upstart in the polyclonal antibody biz just lined up $50M for its plan to disrupt a multibillion-dollar business

07/21/2017
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
©Copyright 2023 GigaGen. All Rights Reserved. | Privacy Policy | Terms | Disclaimer
  • Twitter
  • LinkedIn
Scroll to top